Organizational Capability and Competitive Advantage in Pharmaceutical Product Development

Most existing researches treated pharmaceutical product development process as a sort of “black box.” This paper, however, will focus on the product development process to explore the organizational capabilities and effective development patterns. Interviews and statistical analyses with leading com...

Full description

Bibliographic Details
Main Author: Kenichi KUWASHIMA
Format: Article
Language:English
Published: Global Business Research Center 2003-04-01
Series:Annals of Business Administrative Science
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/abas/2/2/2_21/_pdf/-char/en
_version_ 1818565439010111488
author Kenichi KUWASHIMA
author_facet Kenichi KUWASHIMA
author_sort Kenichi KUWASHIMA
collection DOAJ
description Most existing researches treated pharmaceutical product development process as a sort of “black box.” This paper, however, will focus on the product development process to explore the organizational capabilities and effective development patterns. Interviews and statistical analyses with leading companies in Japanese pharmaceutical industry indicated that “go or no-go decision” is the significant organizational capability, in fact differing among companies, which effects performances in pharmaceutical product development process. This organizational capability is accumulated through experiences in pharmaceutical product development projects.
first_indexed 2024-12-14T01:41:22Z
format Article
id doaj.art-d399ce7b1e58415dbe021c4442142f54
institution Directory Open Access Journal
issn 1347-4464
1347-4456
language English
last_indexed 2024-12-14T01:41:22Z
publishDate 2003-04-01
publisher Global Business Research Center
record_format Article
series Annals of Business Administrative Science
spelling doaj.art-d399ce7b1e58415dbe021c4442142f542022-12-21T23:21:44ZengGlobal Business Research CenterAnnals of Business Administrative Science1347-44641347-44562003-04-0122212810.7880/abas.2.21abasOrganizational Capability and Competitive Advantage in Pharmaceutical Product DevelopmentKenichi KUWASHIMA0Graduate School of Business Sciences, University of TsukubaMost existing researches treated pharmaceutical product development process as a sort of “black box.” This paper, however, will focus on the product development process to explore the organizational capabilities and effective development patterns. Interviews and statistical analyses with leading companies in Japanese pharmaceutical industry indicated that “go or no-go decision” is the significant organizational capability, in fact differing among companies, which effects performances in pharmaceutical product development process. This organizational capability is accumulated through experiences in pharmaceutical product development projects.https://www.jstage.jst.go.jp/article/abas/2/2/2_21/_pdf/-char/enproduct developmentorganizational capabilitypharmaceutical industry
spellingShingle Kenichi KUWASHIMA
Organizational Capability and Competitive Advantage in Pharmaceutical Product Development
Annals of Business Administrative Science
product development
organizational capability
pharmaceutical industry
title Organizational Capability and Competitive Advantage in Pharmaceutical Product Development
title_full Organizational Capability and Competitive Advantage in Pharmaceutical Product Development
title_fullStr Organizational Capability and Competitive Advantage in Pharmaceutical Product Development
title_full_unstemmed Organizational Capability and Competitive Advantage in Pharmaceutical Product Development
title_short Organizational Capability and Competitive Advantage in Pharmaceutical Product Development
title_sort organizational capability and competitive advantage in pharmaceutical product development
topic product development
organizational capability
pharmaceutical industry
url https://www.jstage.jst.go.jp/article/abas/2/2/2_21/_pdf/-char/en
work_keys_str_mv AT kenichikuwashima organizationalcapabilityandcompetitiveadvantageinpharmaceuticalproductdevelopment